Rene Kuijten - Profile and Investment Details

Investor Profile

Rene Kuijten is a Venture Capital, Private Equity Firm based in Amsterdam, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma, McKinsey & Company, Sapiens Steering Brain Stimulation, ArtiosSyntaxin, Asoyia, eTheRNA immunotherapies, Vico Therapeutics, DNA Script, Hyperion Therapeutics, VarmX, Hybrigenics, Atlantic Therapeutics, Sequana Medical, Xeltis, Pronota, ImCheck Therapeutics, Prosensa, Orphazyme, Heart Metabolics, ViCentra, Nexstim, Nederlandse Vereniging van Participatiemaatschappijen (NVP), XyloCor Therapeutics, Mendor, Oncode Accelerator, BMEYE, OneProjects, Cardior Pharmaceuticals, Seahorse Bioscience, Nkarta Therapeutics, Simplify Medical, Luxendo, Binx Health, Affimed, Pasteuria Bioscience, Artios Pharma, Pivot Park, Cellerix, GTX medical, IlluminOss Medical, Endotronix, Kreatech Diagnostics, Nouscom, Universiteit Utrecht, Celladon, Mint Solutions, Neuravi, Rainier Therapeutics, Rotation Medical, Alizé Pharma, Vivasure Medical, Immunic, Kuros Biosciences, Merus, Ministerie van OCW, Promethera Biosciences, Neurent Medical, Kiadis Pharma, SNIPR Biome, Harvest Automation, arGEN-X, Curetis, Vivoryon Therapeutics, ActoGeniX, Pharvaris, Cobalt Technologies, Trinity Biosystems, OxThera, Arvelle Therapeutics, Vivendy Therapeutics, Oncode Institute, . Over time, Rene Kuijten has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rene Kuijten is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Digital Infrastructure, Equities, Investment Management, Customer Engagement, Infrastructure, Strategic Partnerships, Life Science, Portfolio Management, Industrial Technology, Mobile, Manufacturing, Biotechnology, Social Tech, Productivity Software, Innovation, Digital Transformation, Health Diagnostics, Renewable Energy, Medical, B2B, Real Estate, Therapeutics, Financial Advisory, Health Tech, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Rene Kuijten, as their portfolio suggests a familiarity and interest in this area.

Understanding Rene Kuijten’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.